Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: Prog Retin Eye Res. 2022 Oct 22;95:101133. doi: 10.1016/j.preteyeres.2022.101133

Fig. 10. Innovative therapeutic approaches for aniridia-associated keratopathy (AAK).

Fig. 10.

To overcome the limitations of current therapeutic options for AAK, innovative approaches are under evaluation including gene therapy (adeno-associated virus (AAV) delivery, in vivo gene editing through clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and nonsense mutation suppression) as well as drug repurposing.